In August 2002, Trauer bio-tech Co.limited was officially established and obtained business licence
In August 2003, we obtained medical devices manufacturing approval with the certificates of manufacturing.
In January 2004, we obtained “collagen dressing” medical device registration approval and started manufacturing and selling collagen dressing
In June 2005, we obtained “collagen dressing”utility model patents
During this period, we gained a foothold in R&D and made achievements in process technology and customer accumulation in the early stage, which, paved a way for sustainable development in the future
In March 2008, the company was relocated to science city
In February 2010, the first type III medical device--”collagen sponge”gained registration certificate. During this period, the company kept engaging in collagen industrialization, enrich categories of medical devices and commencing R&D of collagen eye drop, collagen gel, collagen sponge, among others.
At the same time, the company has invested more on biological skin care, applying active collagen to biological skin care products.
In November 2013, the construction project of second factory was successfully completed and approved before put into production.
In October 2013, the company officially changed its name to "Guangzhou Trauer Biotechnology Co.limited And in October 2014, the company was listed on the NEEQ (national equity exchange and quotation).
In October 2013, Trauemy Mall was officially in service.
In January 2015, the Trauemy franchise store was opened.
In February 2016, Trauer Cloud completed the business registration, and the online platform "cloud skin care" selling dermatology products was launched and operated.
In April 2016, TREMENT Medical completed its business registration and officially entered the field of precision medicine.
During this period, the company actively broadened its range of business, and e-commerce became a new platform to drive growth; at the same time, we advanced into internet marketing and precision medicine for a diversified development.
At the end of 2018, the Company opened the TRAUER franchise store in Tmall, setting up the e-commerce platform to sell medical devices.
In September 2019, the company was certified to use industrial site in Guangzhou Sino-Singapore Knowledge City and commenced the construction of the new workplace.
From 2020 to 2021, the company was selected as a provincial/national 'small giant' enterprise with professionalism, refinement, uniqueness and novelty, a private leading enterprise in Guangzhou, and a postdoctoral innovation practice base in Guangzhou.
In 2019 and 2021, Xinyu Chuangjin Biomedical Technology Co. Ltd. and Hangzhou Branch of Guangzhou Trauemy Biotechnology Co. Ltd. were set up respectively in order to “go global” in production and e-commerce.
By 2022, Xinyu Chuangjin has obtained 9 Type I medical device products and 4 Type II medical device products registration certificates and achieved mass production, and Hangzhou Branch set up a new record in e-commerce with sales over 13 million RMB in one day during the anniversary sales promotion, .
In 2022, the construction of the new working site was completed and accepted.
With twenty years of efforts on technology and marketing channel arrangement, the company advanced into a rapid development stage. During this period, the range of product is more abundant, with a large-scale and systematic capacity for R&D, production and sales of active collagen raw materials, medical devices and bio-skin care products.
